326 related articles for article (PubMed ID: 32201226)
1. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
3. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
Liu L; Takeda K; Akkoyunlu M
Front Immunol; 2020; 11():1569. PubMed ID: 32849532
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
5. Administration of a microRNA-21 inhibitor improves the lupus-like phenotype in MRL/lpr mice by repressing Tfh cell-mediated autoimmune responses.
Gao X; Song Y; Du P; Yang S; Cui H; Lu S; Hu L; Liu L; Jia S; Zhao M
Int Immunopharmacol; 2022 May; 106():108578. PubMed ID: 35124415
[TBL] [Abstract][Full Text] [Related]
6. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
Wu XN; Ye YX; Niu JW; Li Y; Li X; You X; Chen H; Zhao LD; Zeng XF; Zhang FC; Tang FL; He W; Cao XT; Zhang X; Lipsky PE
Sci Transl Med; 2014 Jul; 6(246):246ra99. PubMed ID: 25101889
[TBL] [Abstract][Full Text] [Related]
7. Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.
Yang M; Yang B; Deng D
J Cell Mol Med; 2021 Nov; 25(21):10291-10305. PubMed ID: 34668631
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
10. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
12. The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation.
Dai R; Lu R; Ahmed SA
PLoS One; 2016; 11(4):e0153509. PubMed ID: 27070142
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus.
Jin X; Chen J; Wu J; Lu Y; Li B; Fu W; Wang W; Cui D
Front Immunol; 2022; 13():928359. PubMed ID: 36119056
[TBL] [Abstract][Full Text] [Related]
15. Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3.
Jang SG; Lee J; Hong SM; Song YS; Kim MJ; Kwok SK; Cho ML; Park SH
J Transl Med; 2021 Feb; 19(1):86. PubMed ID: 33632240
[TBL] [Abstract][Full Text] [Related]
16. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice.
Yang X; Yang J; Chu Y; Wang J; Guan M; Zhu X; Xue Y; Zou H
PLoS One; 2013; 8(4):e62855. PubMed ID: 23638156
[TBL] [Abstract][Full Text] [Related]
17. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
[TBL] [Abstract][Full Text] [Related]
19. Prolactin Increases the Frequency of Follicular T Helper Cells with Enhanced IL21 Secretion and OX40 Expression in Lupus-Prone MRL/lpr Mice.
Alemán-García YP; Vaquero-García RM; Flores-Fernández R; Fuentes-Pananá EM; Gorocica-Rosete P; Pizaña-Venegas A; Chávez-Sanchéz L; Blanco-Favela F; Legorreta-Haquet MV; Chávez-Rueda AK
J Immunol Res; 2021; 2021():6630715. PubMed ID: 33763492
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
